IgA 肾病临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 IgA 肾病（国际通用名 IgA nephropathy）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。
正在招募的IgA 肾病新药试验
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
III 期招募中美国Argentina澳大利亚加拿大NCT06858319Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
III 期招募中中国NCT07390123Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
II 期招募中美国ArgentinaIsraelMalaysiaNCT06797518A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
III 期招募中美国Argentina澳大利亚BelgiumNCT06935357Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy
不适用招募中法国NCT05791162Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy
不适用招募中RussiaNCT07074951Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
IV 期招募中意大利NCT04662723National Registry of Rare Kidney Diseases
不适用招募中英国NCT06065852Study of WAL0921 in Patients With Glomerular Kidney Diseases
II 期招募中美国澳大利亚IndiaMalaysiaNCT06466135Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
早期 I 期招募中中国NCT07507201Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
II 期招募中澳大利亚NCT07606352Chinese Adults With Kidney Disease
II 期招募中中国NCT07522099
IgA 肾病试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。